Skip to main content
. 2019 Oct 16;4(2):307–319. doi: 10.1007/s41669-019-00183-w
Intraoperative removal of ticagrelor by CytoSorb® can improve the outcomes for patients who require emergent cardiac surgery, and can reduce the preoperative hospital stay for patients who require urgent cardiac surgery.
Intraoperative removal of ticagrelor by CytoSorb is a cost-saving (dominant) intervention for patients who require emergent and urgent cardiac surgery in the UK.